Aoki F Y, Tyrrell D A, Hill L E
Lancet. 1975 Mar 22;1(7908):660-2. doi: 10.1016/s0140-6736(75)91761-4.
A rabies vaccine, prepared in human diploid-cell culture, was given intradermally (i.d.) or intramuscularly (i.m.) to 35 volumteers who had not previously received prophylactic immunisation. Rabies neutralising antibody titres rose sharply after the first dose, and 4 weeks after the second dose all titres were above 1/80 (1-7 i.u. per ml.). Immunisation via the i.d. and i.m. routes was equally successful in terms of likely immune status, but the i.d. rate was associated with many more local sideeffects.
一种用人二倍体细胞培养制备的狂犬病疫苗,通过皮内(i.d.)或肌肉内(i.m.)途径给予35名先前未接受过预防性免疫的志愿者。首次接种后狂犬病中和抗体滴度急剧上升,第二次接种后4周所有滴度均高于1/80(每毫升1 - 7国际单位)。就可能的免疫状态而言,皮内和肌肉内途径免疫同样成功,但皮内途径的接种伴随着更多的局部副作用。